| 詳細情報 |  |
|---|---|
| 関連リンク |  |
| 探す |  |
論文 (178件)
- Yuki Ujihara, Kazuki Tamura, Shohei Mori, Dar In Tai, Po Hsiang Tsui, Shinnosuke Hirata, Kenji Yoshida, Hitoshi Maruyama, Tadashi Yamaguchi. Correction to: Modified multi-Rayleigh model-based statistical analysis of ultrasound envelope for quantification of liver steatosis and fibrosis (Journal of Medical Ultrasonics, (2024), 51, 1, (5-16), 10.1007/s10396-023-01354-3). Journal of Medical Ultrasonics. 2024. 51. 3. 555
- Yuki Ujihara, Kazuki Tamura, Shohei Mori, Dar-In Tai, Po-Hsiang Tsui, Shinnosuke Hirata, Kenji Yoshida, Hitoshi Maruyama, Tadashi Yamaguchi. Modified multi-Rayleigh model-based statistical analysis of ultrasound envelope for quantification of liver steatosis and fibrosis. Journal of Medical Ultrasonics. 2023
- Zhaohui Bai, Nahum Méndez-Sánchez, Fernando Gomes Romeiro, Andrea Mancuso, Cyriac Abby Philips, Frank Tacke, Metin Basaranoglu, Massimo Primignani, Mostafa Ibrahim, Yu Jun Wong, et al. Use of albumin infusion for cirrhosis-related complications: An international position statement. JHEP reports : innovation in hepatology. 2023. 5. 8. 100785-100785
- Shuichiro Shiina, Hitoshi Maruyama, Maki Tobari, Tatsuya Yamashita. Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma. Hepatology international. 2023
- Yuki Ujihara, Kazuki Tamura, Shohei Mori, Shinnosuke Hirata, Kenji Yoshida, Hitoshi Maruyama, Tadashi Yamaguchi. Improved robustness of multi-component analysis in amplitude envelope statistics using plane waves. Japanese Journal of Applied Physics. 2023. 62. SJ. SJ1043-SJ1043
- Michio Saeki, Hironao Okubo, Yusuke Takasaki, Eisuke Nakadera, Yuka Fukuo, Hiroo Fukada, Yuta Hotchi, Hitoshi Maruyama, Shigehiro Kokubu, Shuichiro Shiina, et al. The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension. Journal of clinical medicine. 2023. 12. 7
- KEITA OGAWA, TETSUHIRO CHIBA, MASATO NAKAMURA, JUN ARAI, JIAQI ZHANG, YAOJIA MA, NA QIANG, JUNJIE AO, SAE YUMITA, TAKAMASA ISHINO, et al. Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors. Anticancer Research. 2023. 43. 3. 1043-1052
- Hitoshi Maruyama, Maki Tobari, Hiroaki Nagamatsu, Tadashi Yamaguchi, Shuichiro Shiina. Ablation for Benign Liver Tumors: Current Concepts and Limitations. Journal of clinical and translational hepatology. 2023. 11. 1. 244-252
- Hiroaki Kanzaki, Tetsuhiro Chiba, Tatsuya Kaneko, Junjie Ao, Motoyasu Kan, Ryosuke Muroyama, Shingo Nakamoto, Tatsuo Kanda, Hitoshi Maruyama, Jun Kato, et al. The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells. International journal of molecular sciences. 2022. 23. 14
- Hitoshi Maruyama, Maki Tobari, Hiroaki Nagamatsu, Suichiro Shiina, Tadashi Yamaguchi. Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis. Frontiers in medicine. 2022. 9. 1057045-1057045
- Keita Ogawa, Hiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao, Na Qiang, Yaojia Ma, Jiaqi Zhang, Sae Yumita, Takamasa Ishino, Hidemi Unozawa, et al. Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience. Journal of Cancer. 2022. 13. 8. 2656-2661
- Kazufumi Kobayashi, Sadahisa Ogasawara, Aya Takahashi, Yuya Seko, Hidemi Unozawa, Rui Sato, Shunji Watanabe, Michihisa Moriguchi, Naoki Morimoto, Satoshi Tsuchiya, et al. Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma. Liver cancer. 2022. 11. 1. 48-60
- Yuko Kusakabe, Tetsuhiro Chiba, Motohiko Oshima, Shuhei Koide, Ola Rizq, Kazumasa Aoyama, Junjie Ao, Tatsuya Kaneko, Hiroaki Kanzaki, Kengo Kanayama, et al. EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma. Scientific reports. 2021. 11. 1. 21396-21396
- Hitoshi Maruyama, Shuichiro Shiina. Connection between HPS and ACLF: a solution of chaos?. Hepatology international. 2021. 15. 5. 1049-1052
- Keisuke Koroki, Naoya Kanogawa, Susumu Maruta, Sadahisa Ogasawara, Yotaro Iino, Masamichi Obu, Tomomi Okubo, Norio Itokawa, Takahiro Maeda, Masanori Inoue, et al. Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. Liver cancer. 2021. 10. 5. 473-484
- Hitoshi Maruyama, Shuichiro Shiina. Collaterals in portal hypertension: anatomy and clinical relevance. Quantitative imaging in medicine and surgery. 2021. 11. 8. 3867-3881
- Yusuke Sato, Kazuki Tamura, Shohei Mori, Dar-In Tai, Po-Hsiang Tsui, Kenji Yoshida, Shinnosuke Hirata, Hitoshi Maruyama, Tadashi Yamaguchi. Fatty liver evaluation with double-Nakagami model under low-resolution conditions. Japanese Journal of Applied Physics. 2021. 60. SD. SDDE06-SDDE06
- Junjie Ao, Tetsuhiro Chiba, Shuhei Shibata, Akane Kurosugi, Na Qiang, Yaojia Ma, Motoyasu Kan, Terunao Iwanaga, Takafumi Sakuma, Hiroaki Kanzaki, et al. Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells. Biochemical and biophysical research communications. 2021. 549. 171-178
- Yotaro Iino, Hitoshi Maruyama, Rintaro Mikata, Shin Yasui, Keisuke Koroki, Hiroki Nagashima, Masami Awatsu, Ayako Shingyoji, Yuko Kusakabe, Kazufumi Kobayashi, et al. Percutaneous Two-Dimensional Shear Wave Elastography for Diagnosis of Pancreatic Tumor. Diagnostics (Basel, Switzerland). 2021. 11. 3
- Hiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao, Keisuke Koroki, Kengo Kanayama, Susumu Maruta, Takahiro Maeda, Yuko Kusakabe, Kazufumi Kobayashi, Naoya Kanogawa, et al. The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma. Scientific reports. 2021. 11. 1. 5303-5303
前のページに戻る
